Compare ADMA Biologics Inc (ADMA) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Enveric Biosciences Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: ADMA Biologics Inc is far larger — about 358.1× Enveric Biosciences Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | ENVB | |
|---|---|---|
Market Cap | $2.22B | $6.20M |
Sector | Health | Health |
52-Week High | $20.38 | $17.40 |
52-Week Low | $7.60 | $1.27 |
Enterprise Value | $2.29B | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
